SRF Call for Papers is Now Closed

Thank you for your submissions.

Attention, students, residents and fellows!

We invite you to submit a proposal to present a poster at the 2021 NAPCRG Annual Meeting to be held virtually November 19-23, 2021. Proposals on any topic relating to completed or in-progress primary care research are welcome from researchers throughout North America and the rest of the world.

New for 2021, NAPCRG is pleased to offer publishing opportunities for completed research works. SRF poster abstracts for completed research will be eligible to be published in the Annals of Family Medicine, a top-ranked bimonthly primary care research journal. Published abstracts will appear in digital form following the meeting.

SUBMISSION CATEGORIES:  

For the 2021 NACPRG Annual Meeting, abstracts are being accepted from students, residents, and fellows in the following categories.

Because of the meeting's virtual format, accepted SRF poster presentations will be housed in a virtual poster hall and viewable at the convenience of attendees. Presenters may be asked to showcase their virtual posters as a 10-minute presentation during designated times during the NAPCRG Annual Meeting. Due to the virtual format of the meeting, presenters must be comfortable using Zoom screen share function to display and advance their slides. 

Poster on Completed Research

If you are submitting an abstract in this category, the research must be complete at the time of the Call for Papers submission deadline.

Poster on Research in Progress

If you are submitting an abstract in this category, the research must be in progress at the time of the Call for Papers submission deadline. If your research is in progress at the time of the submission deadline but will be complete by the meeting, you should still submit your abstract as a poster on research in progress.


GENERAL RULES FOR ALL SUBMISSIONS:  

  1. Submissions must be submitted online through the NAPCRG website (www.napcrg.org) no later than August 16, 2021.
  2. Submissions must meet all the requirements of the proposed category.
  3. A non-refundable fee of $20 U.S. is required for each submission. Visa, MasterCard and American Express are accepted. 
  4. If accepted, all presenters must register for the conference and pay the appropriate registration fees.

Please Note:

The NAPCRG submission system considers co-authors and co-presenters one and the same. Anyone that wishes to be listed on the abstract will need to create a profile, including co-authors and co-presenters. 

The lead presenter is the individual that will be listed in the program book as the main contact for the presentation. All other names will appear in the mobile app and on the abstract. 

To add co-authors or presenters to your submission please be sure to follow the instructions listed on the last page of the submission form. This page will prompt you to send a link to fellow authors to add themselves to the submission by completing a disclosure form. Please see example below.


SUBMISSION FORMAT INSTRUCTIONS:  

Length: Limit abstracts to 2,500 characters (including spaces). This does NOT include the title or author(s).

Language: Abstracts must be submitted in English. 

Learning Objectives: Our CME requires each submission to include at least two learning objectives. Submissions that fail to include this information will not be considered. Please follow these instructions.

  1. Clearly describe what you want learners to take away and implement after the session in active, measurable terms (e.g. - define, interpret, explain, apply). 
  2. Each objective must be specific, concise and limited to one sentence. 
  3. Example - "On completion of this session, participants should be able to identify and describe the three primary tenets of the Patient Self-Efficacy Model.”

Abstract Format:

  • Type the body of the abstract as one paragraph.
  • The abstract must be written in the third person.
  • The abstract must contain the appropriate subheadings described below.
  • The abstract should NOT contain references or acknowledgments.
  • The abstract should NOT contain charts, graphics, references, or acknowledgments.
  • Abstracts will be published as submitted. Before submitting your abstract, check carefully to make sure it contains no spelling or typographical errors.
  • Type your abstract in a text document and then copy and paste it into the abstract field during the online submission process. Do not type your abstract directly into the abstract field as the page may time out forcing you to restart the process.

Abstract Subheadings:

Context: The abstract should begin with a sentence or two summarizing the rationale for the study, providing the clinical (or other) reason for the study question. In addition, the author should give a sentence or two about the importance of this work to family medicine/primary care.

Objective: State the objective or study question addressed (e.g., to determine whether…). If more than one objective is addressed, the main objective should be indicated and only key secondary objectives stated.

Study Design: Describe the basic design of the study. Use descriptors such as double blind, placebo controlled RCT, cohort, case control survey, case series, cost-effectiveness analysis, or qualitative study. For new analyses of existing data sets (secondary data analysis), the data set should be named and the basic study design disclosed.

Setting or Dataset: Describe the study setting(s) such as general community, a primary care or referral center, private or institutional practice, or ambulatory or hospitalized care. Patients or Other Participants: State the important eligibility (inclusion and exclusion) criteria and key sociodemographic features of participants. Provide numbers of participants and how they were selected.

Population Studied: Briefly describe the inclusion and exclusion criteria and the number of participants (or studies) included. 

Intervention/Instrument (as pertinent): Describe the essential features of any interventions. The intervention should be named by its common clinical name (e.g., the nonproprietary drug name propranolol).

Main and Secondary Outcome Measures (if any): Give the primary study outcome measurements. Measurements that require explanation for a general medical readership should be defined.

Results or Anticipated Results: Give the main results or anticipated results of the study.

Conclusions: State methodological or conceptual problem that is being posed.

Note: For brevity, parts of the abstract should be written in phrases rather than complete sentences (e.g., “Design: Double-blind randomized trial.”)

 

QUESTIONS? If you have questions about SRF Annual Meeting submissions, please contact NAPCRG at napcrgoffice@naprcrg.org

Social Media

Address

NAPCRG
11400 Tomahawk Creek Parkway
Leawood, KS 66211
800.274.7928
Email: napcrgoffice@napcrg.org